Posted on 8/3/17
Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership. Cardurion, a . . .
Posted on 8/3/17
Cedar Valley Medical Specialists, P.C. Selects eClinicalWorks for Its More Than 90 Providers
WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, a leader in healthcare IT solutions, announces that Cedar Valley Medical Specialists, P.C. (CVMS), an independent medical organization located in Waterloo, Iowa, has . . .
Posted on 8/2/17
Momenta Pharmaceuticals Reports Q2 2017 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the second quarter ended June 30, 2017 and . . .
Posted on 8/2/17
Berkshire Hathaway Earnings Preview: An In-Depth Look at Its Most Important Businesses
One of Wall Street's most closely watched companies, Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B), is set to report its second-quarter earnings after the market closes on Aug. 4.With many . . .
Posted on 8/2/17
Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo
Merck & Co (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY) are engaged in a battle of sorts. The two won FDA approval for new non-small cell lung cancer . . .
Posted on 8/1/17
ProEx Physical Therapy Opens 21st New England Clinic
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces the opening of its 21st New England clinic located at 389 . . .
Posted on 8/1/17
Homology Medicines Raises $83.5 Million Series B
Homology Medicines, Inc., a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients
Posted on 8/1/17
Athenahealth, Even After The Monster Beat, Is Worth The Buy
When a company with a market cap over $6 billion operates in one of the most mature and complicated industries beats on earnings per share, investors . . .
Posted on 7/31/17
Athenahealth, Even After The Monster Beat, Is Worth The Buy
When a company with a market cap over $6 billion operates in one of the most mature and complicated industries beats on earnings per share, investors . . .
Posted on 7/31/17
Alkermes Continues to Execute
Alkermes (NASDAQ:ALKS), a biopharmaceutical company focused on diseases of the central nervous system, released its second-quarter earnings results on Thursday, July 27. The report showed that . . .
Posted on 7/31/17
Vertex Pharmaceuticals Incorporated Chugs Along
Vertex Pharmaceuticals (NASDAQ:VRTX) keeps chugging along, generating increased sales for its two cystic fibrosis drugs as it gains additional approvals to treat more patients, and producing . . .
Posted on 7/31/17
Buffett's Berkshire Hathaway Has Held These 2 Stocks For Decades
Perhaps the ultimate buy-and-hold investor, Warren Buffett has kept a small selection of stocks in his Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) for a long time. Make that a . . .
Posted on 7/31/17
Better Buy: Cara Therapeutics Inc. vs. GW Pharmaceuticals plc
Cara Therapeutics Inc. (NASDAQ:CARA), and GW Pharmaceuticals plc (NASDAQ:GWPH)often get lumped in with a stack of risky marijuana stocks, because both are developing drugs derived from . . .
Posted on 7/31/17
NIVEA Men & Real Madrid C.F. Team Up for El Clásico Miami
WILTON, Conn.--(BUSINESS WIRE)--Building on the brand’s global sponsorship of Real Madrid C.F, NIVEA Men, the world’s number one men’s skincare brand, is excited to announce their . . .
Posted on 7/28/17
Bristol-Myers Squibb (BMY) Q2 2017 Results - Earnings Call Transcript
Bristol-Myers Squibb Co. (NYSE:BMY)Q2 2017 Earnings CallJuly 27, 2017 10:30 am ETExecutivesJohn E. Elicker - Bristol-Myers Squibb Co.Giovanni Caforio - Bristol-Myers Squibb Co.Charles A. Bancroft - . . .
Posted on 7/28/17
Boston Scientific (BSX) Q2 2017 Results - Earnings Call Transcript
Boston Scientific Corp. (NYSE:BSX)Q2 2017 Earnings CallJuly 27, 2017 8:00 am ETExecutivesSusan Lisa - Boston Scientific Corp.Michael F. Mahoney - Boston Scientific Corp.Daniel J. Brennan - . . .
Posted on 7/28/17
ImmuCell Closes $1,000,000 Equity Investment
PORTLAND, Maine, July 27, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health . . .
Posted on 7/28/17
Infinity Amends PI3K-Delta,Gamma Agreement with Takeda Oncology
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), today announced that it has amended its license agreement with Takeda Oncology for IPI-549, Infinity's potentially first-in-class immuno-oncology product candidate that . . .
Posted on 7/28/17
WiserTogether Partners with Peers Health
WiserTogether today announces a partnership with Peers Health and the launch of the Return to Health® healthcare treatment platform for Disability and Workers' Compensation Markets. This . . .
Posted on 7/27/17
T2 Biosystems Joins Antimicrobials Working Group as First Diagnostic Member
LEXINGTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, . . .
Posted on 7/27/17
Biogen Q2 2017 Results: Few Steps In The Right Direction
On July 25, 2017, Biogen (NASDAQ:BIIB) reported better-than-expected Q2 2017 results, fueled by a solid performance from the key growth drivers in the Multiple Sclerosis franchise . . .
Posted on 7/27/17
Biogen Positions Itself For The Future
Biogen's (BIIB) product portfolio continues to grow, and the future looks good as well: High capital returns and investments that are poised to generate growth in . . .
Posted on 7/27/17
Biogen Inc Wants to Be the "Fastest-Growing Large-Cap Biotech Company"
Biogen (NASDAQ:BIIB) started the biotech earnings season off with a bang, generating enough revenue for the company to have confidence to increase its revenue guidance for . . .
Posted on 7/27/17
Boston Children's Hospital And Cleveland Clinic Announce Collaboration On Pediatric Heart Care
Boston Children's Hospital and Cleveland Clinic announced today that they have entered into an agreement to provide complex pediatric heart services through Cleveland Clinic's national network, . . .
Posted on 7/26/17
Martin's Point Receives National Accolades as a Great Place to Work in Healthcare
Martin's Point Health Care, a progressive, not-for-profit health care organization, once again received accolades from Great Place to Work®, the global authority on high-trust, high-performance workplace . . .
Boston
